Warning letters, 483s, Recalls, Import Alerts, Audit observations
FDA conducted an inspection at the Hetero Labs Ltd, Warehouse at Nakkapally Village, Vishakapatnam, Andra
Pune based Akriti Pharmaceuticals Private Limited’s EUGMP Certificate remains suspended as the facility remains in
The USFDA inspection of Hetero Labs Ltd, Unit-IX (FEI: 3009093782), Narasapuram, India, conducted in September
Novo Nordisk owned Catalent Indiana sterile products formulation facility was inspected by USFDA in June
The USFDA has issued a Warning Letter to Shiva Analyticals’ Bangalore facility following significant cGMP
Natco Pharma’s sterile products manufacturing facility at Rangareddy, Telengana (FEI 3004540906) was inspected by USFDA
The USFDA issued a notification on 22 May, 2025 on Data Integrity concerns on reliability
The U.S. Food and Drug Administration (FDA) issued a Warning Letter to Aspen Biopharma Labs
The U.S. FDA issued a warning letter to International Laboratories Corp. (FEI 3006403166) following CGMP
Granules India received a warning letter from the USFDA in February 2025. This was along
